Arcturus Therapeutics Holdings Inc.
ARCT· Nasdaq
Released May 9, 2022, after the close
10-Q filed May 9, 2022, 39 days after period end · 0000950170-22-008524
| Metric | Q1 2022 | Q1 2021 | Q1 2020 | Q1 2019 |
|---|---|---|---|---|
| Revenue | $5.24M | $2.13M | $2.65M | $4.35M |
| Net Income | -$51.17M | -$56.35M | -$9.78M | -$6.88M |
| EPS Diluted |
Arcturus Therapeutics Holdings Inc. · CIK 1768224 · Engraved from SEC EDGAR
| -$1.94 |
| -$2.15 |
| -$0.67 |
| -$0.68 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.